![Matthew Charles Tindall](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Matthew Charles Tindall is the founder of Flightpath Biosciences, Inc. He held the titles of President, Chief Executive Officer & Director at the company.
Aktive Positionen von Matthew Charles Tindall
Unternehmen | Position | Beginn |
---|---|---|
Flightpath Biosciences, Inc.
![]() Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Flightpath Biosciences, Inc. operates as a biotechnology company. The firm develops novel therapeutics for the treatment of tick-borne diseases and acute and post treatment Lyme disease. The company was founded by Mark de Souza, Matthew Tindall, and Curtis Scribner in 2019 and is headquartered in Berkeley, CA. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Flightpath Biosciences, Inc.
![]() Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Flightpath Biosciences, Inc. operates as a biotechnology company. The firm develops novel therapeutics for the treatment of tick-borne diseases and acute and post treatment Lyme disease. The company was founded by Mark de Souza, Matthew Tindall, and Curtis Scribner in 2019 and is headquartered in Berkeley, CA. | Health Technology |